Mitochondrial Dysfunction

Mitochondria are primarily important for the generation of cellular energy through oxidative phosphorylation. Byproducts of this process are reactive oxygen species that can cause cell damage if not appropriately regulated. Mitochondria also play roles in other cellular functions including buffering of critical intracellular signaling pathways and molecules (such as calcium) and regulation of cell death pathways.

Image from NINDS, NIHImage from NINDS, NIHEvidence that mitochondrial dysfunction plays a role in PD comes primarily through the recognition that levels and activity of Complex I, the first enzyme complex in the oxidative phosphorylation pathway, are reduced in post mortem substantia nigra brain tissue from patients with PD. Loss of Complex I can lead to reduced energy production and increased generation of damaging free radicals. Some evidence suggests that mutations and polymorphisms in mitochondrial DNA, which codes for a number of components of the electron transport chain, are also found in people with PD and are potentially associated with PD risk. However, these results are controversial (Schapira, 2008).

Some of the genes associated with PD-related mitochondrial dysfunction are PINK1, LRRK2, DJ-1, and POLG-1.

Reference: 
04 Mar 2010
A recent spate of papers on the functional relationship of PINK1 and parkin, and their involvement in autophagic degradation of mitochondria (mitophagy), have begun to illuminate our understanding of ... 
28 Feb 2010
Recessive Parkinson's disease (PD) genes Parkin and PINK1 have been placed genetically in the same molecular pathway that is essential to maintain the integrity and function of ... 
17 Feb 2010
Mitochondrial complex I deficiency and alpha-synuclein abnormality (enhanced expression, mutation, and nitration) are two major pathological events in the brains of patients with Parkinson's disease ... 
04 Mar 2010
Parkin and PINK1 are two genes implicated in autosomal recessive Parkinson's disease. Parkin is an E3 ligase and a component of the ubiquitin-proteasome system involved in protein ... 
Responses: 8
11 Feb 2010
Mitochondrial dysfunction has been found in brain and other body tissue in Parkinson's disease patients. Additionally, many environmental agents implicated in PD, such as pesticides, function as ... 
Responses: 7
A new lead for potential treatments for Parkinson’s has been discovered by UK researchers in a study funded by the Parkinson’s Disease Society. ... 
04 Mar 2010
This week in The Journal of Neuroscience, Andrews et al. demonstrate the metabolic hormone ghrelin plays a neuroprotective role in nigrostriatal dopaminergic neurons. Ghrelin is more commonly known ... 
10 Nov 2009
Responses: 2
This week in Nature, Tachibana et. al. show mitochondrial DNA (mtDNA) can be replaced in non-human primate oocytes producing healthy offspring. While nuclear DNA is inherited from both parents, ... 
26 Aug 2009
Responses: 1
10 Jun 2009
This group aims to promote interactions, collaborations and the exchange of ideas of those members interested in developing or characterizing genetic disease models, particularly mouse models. ... 
31 May 2009
This study will examine and compare blood samples from healthy volunteers and patients with Parkinson's disease to identify abnormalities associated with Parkinson's disease. Disease symptoms include ... 
14 Aug 2007
The investigational product is a specially formulated TCM and administered in the form of a capsule. Basic pre-clinical studies have suggested that it may have good immunomodulating functions, ... 
19 Mar 2007
The purpose of this trial is to determine if the nutritional supplement creatine slows the progression of Parkinson's disease over time. ...